Literature DB >> 20921924

Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns.

Jonathan L Hecht1, Raina N Fichorova, Vanessa F Tang, Elizabeth N Allred, Thomas F McElrath, Alan Leviton.   

Abstract

Amniotic fluid infection with chorioamnionitis is associated with increased risks of morbidity and mortality in children born prematurely. These risks depend on the presence of a fetal inflammatory response. We measured the concentrations of 25 proteins in the blood of 871 infants born before the 28th wk of gestation and examined their placentas for acute inflammation. Newborns who had inflammatory lesions of the placenta were much more likely than their peers (p < 0.01) to have elevated blood concentrations of cytokines (IL-1β, IL-6, and TNF-α), chemokines (IL-8, MIP-1β, RANTES, and I-TAC), adhesion molecules (ICAM-1, ICAM-3, and E-selectin), matrix metalloproteinases (MMP-1 and MMP-9), the angiogenic inflammatory factor VEGF and its receptor VEGF-R2, and acute phase proteins (SAA and CRP) during the first 3 d after birth. In contrast, newborns with poor placental perfusion had lower levels of inflammatory proteins (p < 0.01; IL-6, RANTES, ICAM-1, ICAM-3, VCAM-1, E-selectin, MMP-1, MMP-9, MPO, and VEGF). An inverse pattern was found between newborn levels of VEGF and its competitive inhibitor VEGF-R1 in both the inflamed and poorly perfused placenta categories. These results confirm the predictive value of placental histology for the presence or absence of elevated inflammatory response in newborns.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20921924      PMCID: PMC3066075          DOI: 10.1203/PDR.0b013e3181fed334

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  34 in total

1.  Mediators of fetal inflammation in extremely low gestational age newborns.

Authors:  O Dammann; T M Phillips; E N Allred; T M O'Shea; N Paneth; L J Van Marter; C Bose; R A Ehrenkranz; F J Bednarek; M Naples; A Leviton
Journal:  Cytokine       Date:  2001-02-21       Impact factor: 3.861

2.  Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates.

Authors:  K B Weatherstone; E A Rich
Journal:  Pediatr Res       Date:  1989-04       Impact factor: 3.756

3.  Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome.

Authors:  P Pacora; T Chaiworapongsa; E Maymon; Y M Kim; R Gomez; B H Yoon; F Ghezzi; S M Berry; F Qureshi; S M Jacques; J C Kim; N Kadar; R Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2002-01

4.  Very low birthweight placenta: clustering of morphologic characteristics.

Authors:  A R Hansen; M H Collins; D Genest; D Heller; S Shen-Schwarz; P Banagon; E N Allred; A Leviton
Journal:  Pediatr Dev Pathol       Date:  2000 Sep-Oct

5.  The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis.

Authors:  B H Yoon; R Romero; J S Park; M Kim; S Y Oh; C J Kim; J K Jun
Journal:  Am J Obstet Gynecol       Date:  2000-11       Impact factor: 8.661

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity.

Authors:  S L Hillier; J Martius; M Krohn; N Kiviat; K K Holmes; D A Eschenbach
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

8.  Fetal vasculitis in preterm newborns: interrelationships, modifiers, and antecedents.

Authors:  O Dammann; E N Allred; A Leviton; S Shen-Schwarz; D Heller; D R Genest; M H Collins
Journal:  Placenta       Date:  2004-11       Impact factor: 3.481

9.  Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study.

Authors:  Alan Leviton; Elizabeth N Allred; Karl C K Kuban; Jonathan L Hecht; Andrew B Onderdonk; T Michael O'shea; Nigel Paneth
Journal:  Pediatr Res       Date:  2010-01       Impact factor: 3.756

10.  Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors.

Authors:  Henrik Døllner; Lars Vatten; Jostein Halgunset; Shahnaz Rahimipoor; Rigmor Austgulen
Journal:  BJOG       Date:  2002-05       Impact factor: 6.531

View more
  57 in total

1.  Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery.

Authors:  Sunita Trivedi; Maria Joachim; Thomas McElrath; Harvey J Kliman; Elizabeth N Allred; Raina N Fichorova; Andrew Onderdonk; Fernanda Heitor; Leila Chaychi; Alan Leviton; Joseph A Majzoub
Journal:  Am J Obstet Gynecol       Date:  2011-12-16       Impact factor: 8.661

2.  Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm.

Authors:  Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-12       Impact factor: 4.147

3.  Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns.

Authors:  J Wells Logan; Elizabeth N Allred; Raina N Fichorova; Stephen Engelke; Olaf Dammann; Alan Leviton
Journal:  Cytokine       Date:  2014-06-02       Impact factor: 3.861

4.  Executive Dysfunction Early Postnatal Biomarkers among Children Born Extremely Preterm.

Authors:  Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-06       Impact factor: 4.147

5.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

6.  Antenatal glucocorticoids and neonatal inflammation-associated proteins.

Authors:  Maheer Faden; Mari Holm; Elizabeth Allred; Raina Fichorova; Olaf Dammann; Alan Leviton
Journal:  Cytokine       Date:  2016-09-24       Impact factor: 3.861

7.  Toll-like receptor-mediated responses by placental Hofbauer cells (HBCs): a potential pro-inflammatory role for fetal M2 macrophages.

Authors:  Omar M Young; Zhonghua Tang; Tracy Niven-Fairchild; Serkalem Tadesse; Graciela Krikun; Errol R Norwitz; Gil Mor; Vikki M Abrahams; Seth Guller
Journal:  Am J Reprod Immunol       Date:  2014-10-24       Impact factor: 3.886

8.  Antecedents of inflammation biomarkers in preterm newborns on days 21 and 28.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann
Journal:  Acta Paediatr       Date:  2015-12-23       Impact factor: 2.299

9.  The relationship between TSH and systemic inflammation in extremely preterm newborns.

Authors:  Carmen L Soto-Rivera; Raina N Fichorova; Elizabeth N Allred; Linda J Van Marter; Bhavesh Shah; Camilia R Martin; Michael S D Agus; Alan Leviton
Journal:  Endocrine       Date:  2014-07-06       Impact factor: 3.633

10.  Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann
Journal:  Early Hum Dev       Date:  2015-12-28       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.